mLPR activates immune cells and secretes IFN-γ/IL-12 cytokines to inhibit lung cancer and reduce bone metastasis so that the mLPR tumor vaccine will provide information and possible uses for mRNA tumor vaccines in the management of lung cancer[144]. The gene discussed is IFNG; the disease is neoplasm.